Project Grant HT9425261E406
Award Date 9/1/26
Completion Date 8/31/30
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- The Defense Health Agency awarded The Children's Hospital of Philadelphia $1,118,257 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to build the Child and Adolescent Thyroid Consortium. The award funds research infrastructure and consortium coordination activities at the Children's Hospital of Philadelphia Research Institute in Philadelphia, Pennsylvania, with a period of performance through August 31, 2029. The Military Medical Research and...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $676,117 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, with completion scheduled for August 31, 2029. The research project focuses on expanded GAA-GGA chimeric repeats in Friedreich Ataxia, a rare neurological genetic disorder. This award supports biomedical research aimed at advancing medical...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $712,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, with completion targeted for August 31, 2027. The award funds the development of a GPC2 CAR T cell-amplifying extracellular vesicle vaccine, representing a translational immunotherapy research initiative aimed at advancing cancer...
- Federal Grant Award Summary The Children's Hospital of Philadelphia (CHOP), through its Research Institute Division, received a $326,712 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2027. The award funds a research initiative titled "Structured Lipid Nutrition Intervention on Symptom Management and Quality of Life," to be conducted at CHOP's...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $934,501 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research focused on developing peptide-centric chimeric antigen receptor (CAR) T-cell therapies for neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors...
- <p>The Defense Health Agency awarded the University of Pennsylvania $499,971 under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2026, to support research repurposing a cancer-approved drug to ameliorate Duchenne muscular dystrophy pathology.</p> <p>The award funds a project grant with a period of performance extending from the award date through June 29, 2028, and performance takes place in Philadelphia, Pennsylvania.</p>
- The U.S. Defense Health Agency awarded a $1,751,725 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME" from September 1, 2023 to August 31, 2027. CHOP, a pediatric hospital and research center, will use this funding from the Military Medical Research and Development program (CFDA 12.420) to transform health care for Service Members and the American public through innovative and impactful...
- The Department of the Army Medical Command awarded a $2,247,531 project grant to The Children's Hospital of Philadelphia through the Military Medical Research and Development program (CFDA 12.420) to conduct a comprehensive evaluation of immune function in patients receiving multimodal therapy for high-risk neuroblastoma. The four-year project beginning September 1, 2022 will apply basic, applied, and advanced biomedical research approaches to transform pediatric cancer care and investigate...
- The Defense Health Agency awarded Cincinnati Children's Hospital Medical Center $910,000 on July 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to define the contemporary natural history and therapeutics impact on cardiomyopathy in Duchenne muscular dystrophy. The award runs through July 14, 2029, with place of performance in Cincinnati, Ohio. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to...
- The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,984,636 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in Friedreich's ataxia mice. The grant, awarded on September 1, 2024, will support this research project over a 4-year period until August 31, 2028. As a leading pediatric research institution, CHOP will leverage...